Molecular mechanisms of the cardiovascular protective effects of polyphenols

British Journal of Nutrition

Volumn 108, Issue 9, 2012, Pages 1532-1549

  Andriantsitohaina, Ramaroson ^a   Auger, Cyril ^b   Chataigneau, Thierry ^b   Étienne Selloum, Nelly ^b   Li, Huige ^c   Martínez, M Carmen ^a   Schini Kerth, Valérie B ^b   Laher, Ismail ^d  

^a UNIVERSITÉ D'ANGERS   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Antioxidants; Cardiovascular system; Endothelium; Free radicals; Nitric oxide; Polyphenols

Indexed keywords

CYCLOOXYGENASE 1; DELPHINIDIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; POLYPHENOL; QUERCETIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; RESVERATROL; SIRTUIN 1;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BIOAVAILABILITY; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CYTOKINE RELEASE; DIET SUPPLEMENTATION; DRUG CYTOTOXICITY; DRUG DOSE COMPARISON; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FRUIT; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERLIPIDEMIA; HYPERTENSION; INSULIN SENSITIVITY; LIMB ISCHEMIA; METABOLIC SYNDROME X; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RED WINE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; RISK REDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; VASOCONSTRICTION; VASODILATATION; VEGETABLE;

ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HUMANS; OXIDATIVE STRESS; PHENOLS; POLYPHENOLS;

EID: 84870054444     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512003406     Document Type: Review

References (196)

1. Chuang CC & McIntosh MK (2011) Potential mechanisms by which polyphenol-rich grapes prevent obesity-mediated inflammation and metabolic diseases. Annu Rev Nutr 31, 155-176.
2. Middleton EJ, Kandaswami C & Theoharides TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673-751.
3. Kuhnau J (1976) The flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 24, 117-191.
4. Hertog MG, Hollman PC, Katan MB, et al. (1993) Intake of potentially anticarcinogenic flavonoids and their determinants in adults in The Netherlands. Nutr Cancer 20, 21-29.
5. Lin J, Rexrode KM, Hu F, et al. (2007) Dietary intakes of flavonols and flavones and coronary heart disease in US women. Am J Epidemiol 165, 1305-1313.
6. Wu X, Beecher GR, Holden JM, et al. (2006) Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J Agric Food Chem 54, 4069-4075.
7. Manach C, Scalbert A, Morand C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747.
8. Walle T, Hsieh F, DeLegge MH, et al. (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32, 1377-1382.
9. Fleming I (2010) Molecular mechanisms underlying the activation of eNOS. Pflugers Arch 459, 793-806.
10. Ungvari Z, Kaley G, de Cabo R, et al. (2010) Mechanisms of vascular aging: new perspectives. J Gerontol A Biol Sci Med Sci 65, 1028-1041.
11. Griendling KK, Sorescu D & Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86, 494-501.
12. Griendling KK & FitzGerald GA (2003) Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS. Circulation 108, 1912-1916.
13. Griendling KK & FitzGerald GA (2003) Oxidative stress and cardiovascular injury: Part II: animal and human studies. Circulation 108, 2034-2040.
14. Virdis A, Ghiadoni L & Taddei S (2010) Human endothelial dysfunction: EDCFs. Pflugers Arch 459, 1015-1023.
15. Sofi F, Cesari F, Abbate R, et al. (2008) Adherence to Mediterranean diet and health status: meta-analysis. BMJ 337, a1344.
16. Renaud S & de Lorgeril M (1992) Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 339, 1523-1526.
17. Basu A, Rhone M & Lyons TJ (2010) Berries: emerging impact on cardiovascular health. Nutr Rev 68, 168-177.
18. Fitzpatrick DF, Hirschfield SL & Coffey RG (1993) Endothelium-dependent vasorelaxing activity of wine and other grape products. Am J Physiol 265, H774-H778.
19. Schini-Kerth VB, Auger C, Kim JH, et al. (2010) Nutritional improvement of the endothelial control of vascular tone by polyphenols: role of NO and EDHF. Pflugers Arch 459, 853-862.
20. Andriambeloson E, Kleschyov AL, Muller B, et al. (1997) Nitric oxide production and endothelium-dependent vasorelaxation induced by wine polyphenols in rat aorta. Br J Pharmacol 120, 1053-1058.
21. Ndiaye M, Chataigneau M, Lobysheva I, et al. (2005) Red wine polyphenol-induced, endothelium-dependent NO-mediated relaxation is due to the redox-sensitive PI3-kinase/Akt-dependent phosphorylation of endothelial NO-synthase in the isolated porcine coronary artery. FASEB J 19, 455-457.
22. Duthie GG, Pedersen MW, Gardner PT, et al. (1998) The effect of whisky and wine consumption on total phenol content and antioxidant capacity of plasma from healthy volunteers. Eur J Clin Nutr 52, 733-736.
23. Duarte J, Andriambeloson E, Diebolt M, et al. (2004) Wine polyphenols stimulate superoxide anion production to promote calcium signaling and endothelial-dependent vasodilatation. Physiol Res 53, 595-602.
24. Madeira SV, Auger C, Anselm E, et al. (2009) eNOS activation induced by a polyphenol-rich grape skin extract in porcine coronary arteries. J Vasc Res 46, 406-416.
25. Anselm E, Chataigneau M, Ndiaye M, et al. (2007) Grape juice causes endothelium-dependent relaxation via a redox-sensitive Src-and Akt-dependent activation of eNOS. Cardiovasc Res 73, 404-413.
26. Chalopin M, Tesse A, Martinez MC, et al. (2010) Estrogen receptor alpha as a key target of red wine polyphenols action on the endothelium. PLoS One 5, e8554.
27. Peng N, Clark JT, Prasain J, et al. (2005) Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 289, R771-R775.
28. Machha A & Mustafa MR (2005) Chronic treatment with flavonoids prevents endothelial dysfunction in spontaneously hypertensive rat aorta. J Cardiovasc Pharmacol 46, 36-40.
29. Jimenez R, Lopez-Sepulveda R, Kadmiri M, et al. (2007) Polyphenols restore endothelial function in DOCA-salt hypertension: role of endothelin-1 and NADPH oxidase. Free Radic Biol Med 43, 462-473.
30. de Moura RS, Miranda DZ, Pinto AC, et al. (2004) Mechanism of the endothelium-dependent vasodilation and the antihypertensive effect of Brazilian red wine. J Cardiovasc Pharmacol 44, 302-309.
31. Sarr M, Chataigneau M, Martins S, et al. (2006) Red wine polyphenols prevent angiotensin II-induced hypertension and endothelial dysfunction in rats: role of NADPH oxidase. Cardiovasc Res 71, 794-802.
32. Harrison DG, Cai H, Landmesser U, et al. (2003) Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 4, 51-61.
33. Miyazaki R, Ichiki T, Hashimoto T, et al. (2008) SIRT1, a longevity gene, downregulates angiotensin II type 1 receptor expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 28, 1263-1269.
34. Steffen Y, Gruber C, Schewe T, et al. (2008) Mono-O-methylated flavanols and other flavonoids as inhibitors of endothelial NADPH oxidase. Arch Biochem Biophys 469, 209-219.
35. Kane MO, Etienne-Selloum N, Madeira SV, et al. (2010) Endothelium-derived contracting factors mediate the Ang II-induced endothelial dysfunction in the rat aorta: preventive effect of red wine polyphenols. Pflugers Arch 459, 671-679.
36. Agewall S, Wright S, Doughty RN, et al. (2000) Does a glass of red wine improve endothelial function? Eur Heart J 21, 74-78.
37. Engler MB, Engler MM, Chen CY, et al. (2004) Flavonoid-rich dark chocolate improves endothelial function and increases plasma epicatechin concentrations in healthy adults. J Am Coll Nutr 23, 197-204.
38. Duffy SJ, Vita JA, Holbrook M, et al. (2001) Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 21, 1084-1089.
39. Widlansky ME, Hamburg NM, Anter E, et al. (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26, 95-102.
40. Lekakis J, Rallidis LS, Andreadou I, et al. (2005) Polypheno-lic compounds from red grapes acutely improve endothelial function in patients with coronary heart disease. Eur J Cardiovasc Prev Rehabil 12, 596-600.
41. Taubert D, Roesen R, Lehmann C, et al. (2007) Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298, 49-60.
42. Park YK, Kim JS & Kang MH (2004) Concord grape juice supplementation reduces blood pressure in Korean hypertensive men: double-blind, placebo controlled intervention trial. Biofactors 22, 145-147.
43. Aviram M & Dornfeld L (2001) Pomegranate juice consumption inhibits serum angiotensin converting enzyme activity and reduces systolic blood pressure. Atherosclerosis 158, 195-198.
44. Baur JA & Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5, 493-506.
45. Bradamante S, Barenghi L & Villa A (2004) Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev 22, 169-188.
46. Li H & Forstermann U (2009) Resveratrol: a multifunctional compound improving endothelial function. Editorial to: "Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats" by S. Soylemez et al. Cardiovasc Drugs Ther 23, 425-429.
47. Li H, Xia N & Forstermann U (2012) Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26, 102-110.
48. Cao Z & Li Y (2004) Potent induction of cellular anti-oxidants and phase 2 enzymes by resveratrol in cardiomyo-cytes: protection against oxidative and electrophilic injury. Eur J Pharmacol 489, 39-48.
49. Li Y, Cao Z & Zhu H (2006) Upregulation of endogenous antioxidants and phase 2 enzymes by the red wine polyphenol, resveratrol in cultured aortic smooth muscle cells leads to cytoprotection against oxidative and electrophilic stress. Pharmacol Res 53, 6-15.
50. Ungvari Z, Orosz Z, Rivera A, et al. (2007) Resveratrol increases vascular oxidative stress resistance. Am J Physiol Heart Circ Physiol 292, H2417-H2424.
51. Tanno M, Kuno A, Yano T, et al. (2010) Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285, 8375-8382.
52. Xia N, Daiber A, Habermeier A, et al. (2010) Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335, 149-154.
53. Spanier G, Xu H, Xia N, et al. (2009) Resveratrol reduces endothelial oxidative stress by modulating the gene expression of superoxide dismutase 1 (SOD1), glutathione peroxidase 1 (GPx1) and NADPH oxidase subunit (Nox4). J Physiol Pharmacol 60, Suppl. 4, 111-116.
54. Hasko G & Pacher P (2010) Endothelial Nrf2 activation: a new target for resveratrol? Am J Physiol Heart Circ Physiol 299, H10-H12.
55. Ungvari Z, Bagi Z, Feher A, et al. (2010) Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol 299, H18-H24.
56. Thirunavukkarasu M, Penumathsa SV, Koneru S, et al. (2007) Resveratrol alleviates cardiac dysfunction in strepto-zotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radic Biol Med 43, 720-729.
57. Brandes RP & Kreuzer J (2005) Vascular NADPH oxidases: molecular mechanisms of activation. Cardiovasc Res 65, 16-27.
58. Griendling KK (2004) Novel NAD(P)H oxidases in the cardiovascular system. Heart 90, 491-493.
59. Zhang H, Zhang J, Ungvari Z, et al. (2009) Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress. Arterioscler Thromb Vasc Biol 29, 1164-1171.
60. Xu H, Goettsch C, Xia N, et al. (2008) Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med 44, 1656-1667.
61. Forstermann U & Munzel T (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113, 1708-1714.
62. Li H & Forstermann U (2009) Prevention of atherosclerosis by interference with the vascular nitric oxide system. Curr Pharm Des 15, 3133-3145.
63. Alp NJ, McAteer MA, Khoo J, et al. (2004) Increased endo-thelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24, 445-450.
64. Wohlfart P, Xu H, Endlich A, et al. (2008) Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 325, 370-379.
65. Cruz MN, Luksha L, Logman H, et al. (2006) Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol Heart Circ Physiol 290, H1969-H1975.
66. Nicholson SK, Tucker GA & Brameld JM (2010) Physiological concentrations of dietary polyphenols regulate vascular endothelial cell expression of genes important in cardiovascular health. Br J Nutr 103, 1398-1403.
67. Appeldoorn MM, Venema DP, Peters TH, et al. (2009) Some phenolic compounds increase the nitric oxide level in endothelial cells in vitro. J Agric Food Chem 57, 7693-7699.
68. Klinge CM, Wickramasinghe NS, Ivanova MM, et al. (2008) Resveratrol stimulates nitric oxide production by increasing estrogen receptor alpha-Src-caveolin-1 interaction and phosphorylation in human umbilical vein endothelial cells. FASEB J 22, 2185-2197.
69. Pearson KJ, Baur JA, Lewis KN, et al. (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8, 157-168.
70. Murad F (2006) Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development. N Engl J Med 355, 2003-2011.
71. Gojkovic-Bukarica L, Novakovic A, Kanjuh V, et al. (2008) A role of ion channels in the endothelium-independent relaxation of rat mesenteric artery induced by resveratrol. J Pharmacol Sci 108, 124-130.
72. Ruef J, Moser M, Kubler W, et al. (2001) Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol 10, 311-315.
73. Lekli I, Szabo G, Juhasz B, et al. (2008) Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am J Physiol Heart Circ Physiol 294, H859-H866.
74. Touyz RM & Schiffrin EL (2000) Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev 52, 639-672.
75. Geng F, He Y, Yang L, et al. (2010) A rapid assay for angio-tensin-converting enzyme activity using ultra-performance liquid chromatography-mass spectrometry. Biomed Chro-matogr 24, 312-317.
76. 0-trimethoxystilbene. Phytother Res 25, 451-457.
77. Rius C, Abu-Taha M, Hermenegildo C, et al. (2010) Trans-but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-kappaB activation and peroxisome proliferator-activated receptorgamma upregulation. J Immunol 185, 3718-3727.
78. Olholm J, Paulsen SK, Cullberg KB, et al. (2010) Anti-inflammatory effect of resveratrol on adipokine expression and secretion in human adipose tissue explants. Int J Obes (Lond) 34, 1546-1553.
79. Kang L, Heng W, Yuan A, et al. (2010) Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses. Biochimie 92, 789-796.
80. Kumar A & Sharma SS (2010) NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem Biophys Res Commun 394, 360-365.
81. Wang Z, Huang Y, Zou J, et al. (2002) Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro. Int J Mol Med 9, 77-79.
82. Di Santo A, Mezzetti A, Napoleone E, et al. (2003) Resvera-trol and quercetin down-regulate tissue factor expression by human stimulated vascular cells. J Thromb Haemost 1, 1089-1095.
83. Crescente M, Jessen G, Momi S, et al. (2009) Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level. Functional and modelling studies. Thromb Haemost 102, 336-346.
84. Szewczuk LM, Forti L, Stivala LA, et al. (2004) Resveratrol is a peroxidase-mediated inactivator of COX-1 but not COX-2: a mechanistic approach to the design of COX-1 selective agents. J Biol Chem 279, 22727-22737.
85. Patel KR, Scott E, Brown VA, et al. (2011) Clinical trials of resveratrol. Ann N Y Acad Sci 1215, 161-169.
86. Perez-Vizcaino F, Duarte J, Jimenez R, et al. (2009) Anti-hypertensive effects of the flavonoid quercetin. Pharmacol Rep 61, 67-75.
87. Hanasaki Y, Ogawa S & Fukui S (1994) The correlation between active oxygens scavenging and antioxidative effects of flavonoids. Free Radic Biol Med 16, 845-850.
88. Wilms LC, Kleinjans JC, Moonen EJ, et al. (2008) Discriminative protection against hydroxyl and superoxide anion radicals by quercetin in human leucocytes in vitro. Toxicol In vitro 22, 301-307.
89. Sakao K, Fujii M & Hou DX (2009) Clarification of the role of quercetin hydroxyl groups in superoxide generation and cell apoptosis by chemical modification. Biosci Biotechnol Biochem 73, 2048-2053.
90. Perez-Vizcaino F, Duarte J & Andriantsitohaina R (2006) Endothelial function and cardiovascular disease: effects of quercetin and wine polyphenols. Free Radic Res 40, 1054-1065.
91. Khoo NK, White CR, Pozzo-Miller L, et al. (2010) Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels. Free Radic Biol Med 49, 339-347.
92. 2θ-entry into cultured human endothelial cells. Planta Med 71, 520-524.
93. Suri S, Liu XH, Rayment S, et al. (2010) Quercetin and its major metabolites selectively modulate cyclic GMP-depen-dent relaxations and associated tolerance in pig isolated coronary artery. Br J Pharmacol 159, 566-575.
94. Jackson SJ & Venema RC (2006) Quercetin inhibits e NOS, microtubule polymerization, and mitotic progression in bovine aortic endothelial cells. J Nutr 136, 1178-1184.
95. Donnini S, Finetti F, Lusini L, et al. (2006) Divergent effects of quercetin conjugates on angiogenesis. Br J Nutr 95, 1016-1023.
96. Romero M, Jimenez R, Sanchez M, et al. (2009) Quercetin inhibits vascular superoxide production induced by endothelin-1: role of NADPH oxidase, uncoupled eNOS and PKC. Atherosclerosis 202, 58-67.
97. Mackraj I, Govender T & Ramesar S (2008) The antihyper-tensive effects of quercetin in a salt-sensitive model of hypertension. J Cardiovasc Pharmacol 51, 239-245.
98. Actis-Goretta L, Ottaviani JI & Fraga CG (2006) Inhibition of angiotensin converting enzyme activity by flavanol-rich foods. J Agric Food Chem 54, 229-234.
99. Neto-Neves EM, Montenegro MF, Dias-Junior CA, et al. (2010) Chronic treatment with quercetin does not inhibit angiotensin-converting enzyme in vivo or in vitro. Basic Clin Pharmacol Toxicol 107, 825-829.
100. Boesch-Saadatmandi C, Loboda A, Wagner AE, et al. (2011) Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J Nutr Biochem 22, 293-299.
101. Loke WM, Proudfoot JM, Hodgson JM, et al. (2010) Specific dietary polyphenols attenuate atherosclerosis in apolipo-protein E-knockout mice by alleviating inflammation and endothelial dysfunction. Arterioscler Thromb Vasc Biol 30, 749-757.
102. Wein S, Behm N, Petersen RK, et al. (2010) Quercetin enhances adiponectin secretion by a PPAR-gamma independent mechanism. Eur J Pharm Sci 41, 16-22.
103. Hwang MK, Song NR, Kang NJ, et al. (2009) Activation of phosphatidylinositol 3-kinase is required for tumor necrosis factor-alpha-induced upregulation of matrix metalloprotei-nase-9: its direct inhibition by quercetin. Int J Biochem Cell Biol 41, 1592-1600.
104. Huang RY, Yu YL, Cheng WC, et al. (2010) Immuno-suppressive effect of quercetin on dendritic cell activation and function. J Immunol 184, 6815-6821.
105. Heinz SA, Henson DA, Nieman DC, et al. (2010) A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br J Nutr 104, 849-857.
106. Bae SC, Jung WJ, Lee EJ, et al. (2009) Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 28, 56-62.
107. Navarro-Nunez L, Rivera J, Guerrero JA, et al. (2009) Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. Br J Pharmacol 158, 1548-1556.
108. Navarro-Nunez L, Lozano ML, Martinez C, et al. (2010) Effect of quercetin on platelet spreading on collagen and fibrinogen and on multiple platelet kinases. Fitoterapia 81, 75-80.
109. Wright B, Moraes LA, Kemp CF, et al. (2010) A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. Br J Pharmacol 159, 1312-1325.
110. Manach C, Morand C, Crespy V, et al. (1998) Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 426, 331-336.
111. Morand C, Crespy V, Manach C, et al. (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275, R212-R219.
112. Hollman PC, vd Gaag M, Mengelers MJ, et al. (1996) Absorption and disposition kinetics of the dietary antioxi-dant quercetin in man. Free Radic Biol Med 21, 703-707.
113. Galindo P, Rodriguez-Gomez I, Gonzalez-Manzano S, et al. (2012) Glucuronidated quercetin lowers blood pressure in spontaneously hypertensive rats via deconjugation. PLoS One 7, e32673.
114. Felgines C, Talavera S, Texier O, et al. (2005) Blackberry anthocyanins are mainly recovered from urine as methylated and glucuronidated conjugates in humans. J Agric Food Chem 53, 7721-7727.
115. Andriambeloson E, Magnier C, Haan-Archipoff G, et al. (1998) Natural dietary polyphenolic compounds cause endothelium-dependent vasorelaxation in rat thoracic aorta. J Nutr 128, 2324-2333.
116. Azuma K, Ohyama A, Ippoushi K, et al. (2008) Structures and antioxidant activity of anthocyanins in many accessions of eggplant and its related species. J Agric Food Chem 56, 10154-10159.
117. Rahman MM, Ichiyanagi T, Komiyama T, et al. (2006) Superoxide radical-and peroxynitrite-scavenging activity of anthocyanins; structure-activity relationship and their synergism. Free Radic Res 40, 993-1002.
118. Chen CY, Yi L, Jin X, et al. (2010) Delphinidin attenuates stress injury induced by oxidized low-density lipoprotein in human umbilical vein endothelial cells. Chem Biol Interact 183, 105-112.
119. Domitrovic R & Jakovac H (2010) Antifibrotic activity of anthocyanidin delphinidin in carbon tetrachloride-induced hepatotoxicity in mice. Toxicology 272, 1-10.
120. Cvorovic J, Tramer F, Granzotto M, et al. (2010) Oxidative stress-based cytotoxicity of delphinidin and cyanidin in colon cancer cells. Arch Biochem Biophys 501, 151-157.
121. Martin S, Andriambeloson E, Takeda K, et al. (2002) Red wine polyphenols increase calcium in bovine aortic endo-thelial cells: a basis to elucidate signalling pathways leading to nitric oxide production. Br J Pharmacol 135, 1579-1587.
122. Baron-Menguy C, Bocquet A, Guihot AL, et al. (2007) Effects of red wine polyphenols on postischemic neovascu-larization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J 21, 3511-3521.
123. Scarabelli TM, Mariotto S, Abdel-Azeim S, et al. (2009) Targeting STAT1 by myricetin and delphinidin provides efficient protection of the heart from ischemia-reperfusion-induced injury. FEBS Lett 583, 531-541.
124. Lazze MC, Pizzala R, Perucca P, et al. (2006) Anthocyanidins decrease endothelin-1 production and increase endothelial nitric oxide synthase in human endothelial cells. Mol Nutr Food Res 50, 44-51.
125. Khan NQ, Lees DM, Douthwaite JA, et al. (2002) Comparison of red wine extract and polyphenol constituents on endothelin-1 synthesis by cultured endothelial cells. Clin Sci (Lond) 103, Suppl. 48, 72S-75S.
126. Actis-Goretta L, Ottaviani JI, Keen CL, et al. (2003) Inhibition of angiotensin converting enzyme (ACE) activity by flavan-3-ols and procyanidins. FEBS Lett 555, 597-600.
127. Ojeda D, Jimenez-Ferrer E, Zamilpa A, et al. (2010) Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin-and cyanidin-3-O-sambubio-sides from Hibiscus sabdariffa. J Ethnopharmacol 127, 7-10.
128. Kwon JY, Lee KW, Kim JE, et al. (2009) Delphinidin suppresses ultraviolet B-induced cyclooxygenases-2 expression through inhibition of MAPKK4 and PI-3 kinase. Carcino-genesis 30, 1932-1940.
129. Hwang MK, Kang NJ, Heo YS, et al. (2009) Fyn kinase is a direct molecular target of delphinidin for the inhibition of cyclooxygenase-2 expression induced by tumor necrosis factor-alpha. Biochem Pharmacol 77, 1213-1222.
130. Teller N, Thiele W, Boettler U, et al. (2009) Delphinidin inhibits a broad spectrum of receptor tyrosine kinases of the ErbB and VEGFR family. Mol Nutr Food Res 53, 1075-1083.
131. Dreiseitel A, Korte G, Schreier P, et al. (2009) sPhospholi-pase A(2) is inhibited by anthocyanidins. J Neural Transm 116, 1071-1077.
132. Dreiseitel A, Schreier P, Oehme A, et al. (2008) Inhibition of proteasome activity by anthocyanins and anthocyanidins. Biochem Biophys Res Commun 372, 57-61.
133. Garcia-Alonso M, Rimbach G, Rivas-Gonzalo JC, et al. (2004) Antioxidant and cellular activities of anthocyanins and their corresponding vitisins A-studies in platelets, monocytes, and human endothelial cells. J Agric Food Chem 52, 3378-3384.
134. Freedman JE, Parker Cr, Li L, et al. (2001) Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103, 2792-2798.
135. Manach C, Williamson G, Morand C, et al. (2005) Bioavail-ability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81, 230S-242S.
136. Avila M, Ojcius DM & Yilmaz O (2009) The oral microbiota: living with a permanent guest. DNA Cell Biol 28, 405-411.
137. Hwang JT, Kwon DY & Yoon SH (2009) AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. N Biotechnol 26, 17-22.
138. Dasgupta B & Milbrandt J (2007) Resveratrol stimulates AMP kinase activity in neurons. Proc Natl Acad Sci U S A. 104, 7217-7222.
139. Zang M, Xu S, Maitland-Toolan KA, et al. (2006) Polyphenols stimulate AMP-activated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptor-deficient mice. Diabetes 55, 2180-2191.
140. Um JH, Park SJ, Kang H, et al. (2010) AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 59, 554-563.
141. Penumathsa SV, Thirunavukkarasu M, Zhan L, et al. (2008) Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium. J Cell Mol Med 12, 2350-2361.
142. Lu J, Wu DM, Zheng YL, et al. (2010) Quercetin activates AMP-activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol-induced neurotoxicity. J Pathol 222, 199-212.
143. Ahn J, Lee H, Kim S, et al. (2008) The anti-obesity effect of quercetin is mediated by the AMPK and MAPK signaling pathways. Biochem Biophys Res Commun 373, 545-549.
144. Takikawa M, Inoue S, Horio F, et al. (2010) Dietary antho-cyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 140, 527-533.
145. Milne JC, Lambert PD, Schenk S, et al. (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450, 712-716.
146. Michan S & Sinclair D (2007) Sirtuins in mammals: insights into their biological function. Biochem J 404, 1-13.
147. Milne JC & Denu JM (2008) The Sirtuin family: therapeutic targets to treat diseases of aging. Curr Opin Chem Biol 12, 11-17.
148. Guarente L (2006) Sirtuins as potential targets for metabolic syndrome. Nature 444, 868-874.
149. Lagouge M, Argmann C, Gerhart-Hines Z, et al. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127, 1109-1122.
150. Pacholec M, Bleasdale JE, Chrunyk B, et al. (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285, 8340-8351.
151. Liang F, Kume S & Koya D (2009) SIRT1 and insulin resistance. Nat Rev Endocrinol 5, 367-373.
152. Picard F, Kurtev M, Chung N, et al. (2004) Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429, 771-776.
153. Bordone L, Motta MC, Picard F, et al. (2006) Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4, e31.
154. Mattagajasingh I, Kim CS, Naqvi A, et al. (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 104, 14855-14860.
155. Csiszar A, Labinskyy N, Pinto JT, et al. (2009) Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol 297, H13-H20.
156. Chen Z, Peng IC, Cui X, et al. (2010) Shear stress, SIRT1, and vascular homeostasis. Proc Natl Acad Sci U S A 107, 10268-10273.
157. Davis JM, Murphy EA, Carmichael MD, et al. (2009) Querce-tin increases brain and muscle mitochondrial biogenesis and exercise tolerance. Am J Physiol Regul Integr Comp Physiol 296, R1071-R1077.
158. Gehm BD, McAndrews JM, Chien PY, et al. (1997) Resver-atrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 94, 14138-14143.
159. Kuiper GG, Carlsson B, Grandien K, et al. (1997) Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138, 863-870.
160. Le Corre L, Chalabi N, Delort L, et al. (2006) Differential expression of genes induced by resveratrol in human breast cancer cell lines. Nutr Cancer 56, 193-203.
161. Deng JY, Hsieh PS, Huang JP, et al. (2008) Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and-independent pathways. Diabetes 57, 1814-1823.
162. Schlachterman A, Valle F, Wall KM, et al. (2008) Combined resveratrol, quercetin, and catechin treatment reduces breast tumor growth in a nude mouse model. Transl Oncol 1, 19-27.
163. Miodini P, Fioravanti L, Di Fronzo G, et al. (1999) The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br J Cancer 80, 1150-1155.
164. Kuiper GG, Lemmen JG, Carlsson B, et al. (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 139, 4252-4263.
165. Maggiolini M, Vivacqua A, Fasanella G, et al. (2004) The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells. J Biol Chem 279, 27008-27016.
166. Lin JN, Lin VC, Rau KM, et al. (2010) Resveratrol modulates tumor cell proliferation and protein translation via SIRT1-dependent AMPK activation. J Agric Food Chem 58, 1584-1592.
167. Baur JA, Pearson KJ, Price NL, et al. (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444, 337-342.
168. Hou X, Xu S, Maitland-Toolan KA, et al. (2008) SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase. J Biol Chem 283, 20015-20026.
169. Lan F, Cacicedo JM, Ruderman N & Ido Y (2008) SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283, 27628-27635.
170. Curin Y & Andriantsitohaina R (2005) Polyphenols as potential therapeutical agents against cardiovascular diseases. Pharmacol Rep 57, 97-107.
171. Liu Z, Song Y, Zhang X, et al. (2005) Effects of trans-resveratrol on hypertension-induced cardiac hypertrophy using the partially nephrectomized rat model. Clin Exp Pharmacol Physiol 32, 1049-1054.
172. Biala A, Tauriainen E, Siltanen A, et al. (2010) Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Press 19, 196-205.
173. Rush JW, Quadrilatero J, Levy AS, et al. (2007) Chronic resveratrol enhances endothelium-dependent relaxation but does not alter eNOS levels in aorta of spontaneously hypertensive rats. Exp Biol Med (Maywood) 232, 814-822.
174. Behbahani J, Thandapilly SJ, Louis XL, et al. (2010) Resver-atrol and small artery compliance and remodeling in the spontaneously hypertensive rat. Am J Hypertens 23, 1273-1278.
175. Romero M, Jimenez R, Hurtado B, et al. (2010) Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats. Eur J Pharmacol 627, 242-250.
176. Galisteo M, Garcia-Saura MF, Jimenez R, et al. (2004) Effects of chronic quercetin treatment on antioxidant defence system and oxidative status of deoxycorticosterone acetate-salt-hypertensive rats. Mol Cell Biochem 259, 91-99.
177. Diebolt M, Bucher B & Andriantsitohaina R (2001) Wine polyphenols decrease blood pressure, improve NO vasodilatation, and induce gene expression. Hypertension 38, 159-165.
178. Bernatova I, Pechanova O, Babal P, et al. (2002) Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 282, H942-H948.
179. Pechanova O, Bernatova I, Babal P, et al. (2004) Red wine polyphenols prevent cardiovascular alterations in L-NAME-induced hypertension. J Hypertens 22, 1551-1559.
180. Simonyi A, Wang Q, Miller RL, et al. (2005) Polyphenols in cerebral ischemia: novel targets for neuroprotection. Mol Neurobiol 31, 135-147.
181. Yousuf S, Atif F, Ahmad M, et al. (2009) Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res 1250, 242-253.
182. Li C, Yan Z, Yang J, et al. (2010) Neuroprotective effects of resveratrol on ischemic injury mediated by modulating the release of neurotransmitter and neuromodulator in rats. Neurochem Int 56, 495-500.
183. Saleh MC, Connell BJ & Saleh TM (2010) Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors. Neuroscience 166, 445-454.
184. Della-Morte D, Dave KR, DeFazio RA, et al. (2009) Resver-atrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159, 993-1002.
185. Dong W, Li N, Gao D, et al. (2008) Resveratrol attenuates ischemic brain damage in the delayed phase after stroke and induces messenger RNA and protein express for angio-genic factors. J Vasc Surg 48, 709-714.
186. Rivera F, Costa G, Abin A, et al. (2008) Reduction of ischemic brain damage and increase of glutathione by a liposomal preparation of quercetin in permanent focal ischemia in rats. Neurotox Res 13, 105-114.
187. Hwang IK, Lee CH, Yoo KY, et al. (2009) Neuroprotective effects of onion extract and quercetin against ischemic neuronal damage in the gerbil hippocampus. J Med Food 12, 990-995.
188. Sweeney MI, Kalt W, MacKinnon SL, et al. (2002) Feeding rats diets enriched in lowbush blueberries for six weeks decreases ischemia-induced brain damage. Nutr Neurosci 5, 427-431.
189. Ritz MF, Curin Y, Mendelowitsch A, et al. (2008) Acute treatment with red wine polyphenols protects from ischemia-induced excitotoxicity, energy failure and oxidative stress in rats. Brain Res 1239, 226-234.
190. Ritz MF, Ratajczak P, Curin Y, et al. (2008) Chronic treatment with red wine polyphenol compounds mediates neuroprotection in a rat model of ischemic cerebral stroke. J Nutr 138, 519-525.
191. Robich MP, Chu LM, Chaudray M, et al. (2010) Anti-angio-genic effect of high-dose resveratrol in a swine model of metabolic syndrome. Surgery 148, 453-462.
192. Rivera L, Moron R, Zarzuelo A, et al. (2009) Long-term resveratrol administration reduces metabolic disturbances and lowers blood pressure in obese Zucker rats. Biochem Pharmacol 77, 1053-1063.
193. Fischer-Posovszky P, Kukulus V, Tews D, et al. (2010) Resveratrol regulates human adipocyte number and function in a Sirt1-dependent manner. Am J Clin Nutr 92, 5-15.
194. Rivera L, Moron R, Sanchez M, et al. (2008) Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16, 2081-2087.
195. Sutra T, Oiry C, Azay-Milhau J, et al. (2008) Preventive effects of nutritional doses of polyphenolic molecules on cardiac fibrosis associated with metabolic syndrome: involvement of osteopontin and oxidative stress. J Agric Food Chem 56, 11683-11687.
196. Agouni A, Lagrue-Lak-Hal AH, Mostefai HA, et al. (2009) Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in Zucker fatty rats (Fa/Fa). PLoS One 4, e5557.